Suraxavir trial finds faster flu recovery times for male but not female users

A single 40-mg dose of the antiviral drug suraxavir marboxil significantly shortened flu symptom resolution time in male patients aged 5–65, according to research led by the China-Japan Friendship Hospital in China. Intriguingly, suraxavir did not effectively shorten symptom resolution time for female participants in the study.

Leave A Comment

Your email address will not be published. Required fields are marked *